Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Orexigen Resubmits Contrave New Drug Application
Yahoo
Wednesday, December 11, 2013 - 11:25am
tags:
Orexigen, FDA, obesity, Contrave
Supreme Court declines to hear Arthrex appeal of its $85 million patent infringement loss to Smith & Nephew
Mass Device
Wednesday, December 11, 2013 - 11:25am
tags:
Supreme Court, devices, Arthrex, patents, Smith & Nephew, surgical anchors
Boston Scientific May Face A Tough FDA Panel
Forbes
Wednesday, December 11, 2013 - 11:23am
tags:
Boston Scientific, FDA, advisory panels, devices, WATCHMAN, atrial fibrillation
ImmunoCellular's ICT-107 Phase II: Patience Will Pay Off
Seeking Alpha
Wednesday, December 11, 2013 - 11:21am
tags:
ImmunoCellular Therapeutics, ICT-107, glioblastoma multiforme
Cancer drug test results send CytRx shares soaring by 75%
Marketwatch
Wednesday, December 11, 2013 - 11:11am
tags:
CytRx, aldoxorubicin
3 Drugmakers to Watch in the New Year
Motley Fool
Wednesday, December 11, 2013 - 11:10am
tags:
pimavanserin, Acadia, Zerenex, Keryx, Iclusig, Ariad Pharmaceuticals
Agios advances cancer metabolism collaboration with Celgene
Yahoo/Fly on the Wall
Wednesday, December 11, 2013 - 9:35am
tags:
Agios Pharmaceuticals, Celgene, cancer metabolism
A Look Back at Immunomedics' Volatile but Rewarding 2013
Motley Fool
Wednesday, December 11, 2013 - 9:32am
tags:
Immunomedics
What Is Johnson & Johnson's Opportunity In Hepatitis C Market?
Forbes
Wednesday, December 11, 2013 - 9:01am
tags:
JNJ, hepatitis C, Olysio
Eli Lilly: Fasten Your Seat Belts for a Bumpy Ride
Motley Fool
Wednesday, December 11, 2013 - 8:46am
tags:
Eli Lilly, antidepressants, Cymbalta, patents, generics
GlaxoSmithKline is to invest another $330 million on advanced manufacturing in UK
Yahoo/Reuters
Wednesday, December 11, 2013 - 8:44am
tags:
GSK, UK, drug manufacturing
Novartis and Merck Could Boost One Another to New Heights
Motley Fool
Wednesday, December 11, 2013 - 8:43am
tags:
Merck, Novartis, animal health
Female libido drug remains in limbo
Yahoo/AP
Wednesday, December 11, 2013 - 8:38am
tags:
female sexual dysfunction, Sprout Pharmaceuticals, flibanserin
Does Pfizer Have a Bright Future?
Wall St Cheat Sheet
Wednesday, December 11, 2013 - 8:37am
tags:
Pfizer
Geron: Is Imetelstat The 'Aspirin' Of Cancer?
Seeking Alpha
Wednesday, December 11, 2013 - 8:36am
tags:
Geron, imetelstat, stem cells, cancer
Why Talk Of A Hepatitis C Price War Should Act As A Warning To The Pharma Industry-At-Large
Forbes
Wednesday, December 11, 2013 - 8:34am
tags:
hepatitis C, drug pricing, Gilead Sciences, Express Scripts
CVS, Cardinal Health To Start Generic Drug Supplier
Bloomberg
Tuesday, December 10, 2013 - 12:23pm
tags:
Cardinal Health, generics, CVS
Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today
Motley Fool
Tuesday, December 10, 2013 - 11:36am
tags:
Verastem, Cell Therapeutics, Novartis, Geron, imetelstat, Jakavi, myelofibrosis, tosedostat, AML, VS-5584
Novartis/Penn's customized T cell wows ASH with stellar leukemia data
Fierce Biotech
Tuesday, December 10, 2013 - 10:48am
tags:
Novartis, acute lymphoblastic leukemia, CAR T therapy, CTL019
AbbVie's second PhIII hep C study confirms cocktail's promise
Fierce Biotech
Tuesday, December 10, 2013 - 10:47am
tags:
hepatitis C, Enanta Pharmaceuticals, ABT-450, AbbVie

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.